• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Start selling Create your account
Document preview thumbnail
Preview 4 out of 39 pages
Exam (elaborations)

NURSING 565 Final Exam Study Guide

Document preview thumbnail
Preview 4 out of 39 pages

NURSING 565 Final Exam Study Guide NURSING 565 Final Exam Study Guide NURSING 565 Final Exam Study Guide

Content preview

1



NR565 Week 5 Study Outline

Many questions are written to assess your clinical application of the material from the textbook, in real-world
scenarios.

Chapter 24: Drugs used in treating infectious diseases (p. 692-760) SEE DRUG CHART BELOW

Know the following for each drug class (penicillins, cephalosporins, fluoroquinolones, lincosamides, macrolides,
sulfonamides, trimethoprim, nitrofurantoin, lipoglycopeptides):

• • Spectrum of coverage for various organisms

• • Pharmacodynamics

• • Pharmacokinetics

• • Pharmacotherapeutics

• • Clinical indications & dosing

• • ADRs

• • Monitoring

• • Patient education

Antimicrobial resistance
Treatment of Group A and Group B beta streptococci

Cross sensitivity with cephalosporins




Category Bacteriocidal or What do they Pharmacokineti Pregnancy Adverse Effe
Bacteriostatic Treat? cs Category? Safe in
(Indications) pediatrics?
Safe in Lactation?
Penicillins Bacteriocidal; Pcn - Treat aerobic Absorption – - Catergory B - Hypese
(PCN and Amoxicillin) inhibits synthesis and gram positive. from GI tract, - Safe in y
of bacterial cell Red Book depends on lactation - Superin
wall recommends agent, ph of - Safe in n
Used in tx bact. URI, penicillin for stomach/intesti pediatrics - GI
pharyngitis strep, otitis Group ne, presence of - Does not disturub
media, sinusitis, pna, STI, A beta streptococci food; high cross BBB s
wound infx & for Group doses can cause unless - Rash
B beta streptococci GI inflammatio (maculo
due to low upset/diarrhea n lar)
resistance - Change
Distribution – renal
Aminopcn – treat varies in function
gram posivite protein - Candida

,2


anaerobes and binding, well infectio
gram negative distributed, - Seizures
(MSSA, strep, inflammation ability
H.flu, E.coli, enhance - Decreas
Klebsiella, distribution, oral
Neisseria crosses contrapc
meningitides); placenta/breast ves
amoxicillin, milk effectiv
ampicillin; - Interstit
combined with Metabolism – nephriti
betalactamase minimal metab
inhib except for * Severe, type I
nafcillin/oxacill allergic reaction
Pcnase-resistant – in to cephalospori
(pcnase staph, carbapenems, o
strep, MSSA); not Excretion – beta-lactamase
effective against primarily inhibitors may
MRSA; cloxacillin, unchanged in contraindicate u
dicloxacillin, urine, caution penicillins.
methicillin, in renal
nafcillin, oxacillin insufficiency
(increase half
Antipseudomonal – life)
gramneg bacilli
(pseudo
aeruginosa,
enterbacter,
morganella);
piperacillin,
ticarcillin
Cephalosporins – 1st Bactericidal First gram pos Absorption In pregnancy d/t - GI
Generation and limited gram oral, GI tract, increase fluid distuban
(Cephalexin) & Increase in gram neg; doesn’t enter rate of shorter half life, (C.diff)
2nd Generation neg up the CSF, staph aureus, absorption lower serum levels - Alterati
(Cefuroxime) generations and strep, pna/resp infx delayed by and larger Vd blood
3rd Generation decreases in gram (cephalexin, food, IM – clotting
(ceftriaxone) & pos. cefazolin) absorbed by Lactation safe - Combin
4th Generation muscle with alc
(cefepime) Treat surgical Second gram + Pediatrics in (disulfir
prophylaxis, resp and H. flu, more Distribution neonates immature rxn –
1st – narrow spectrum tract infx, strep potent, broader widely renal fx causes flushing
5th – broad spectrum pharyngitis/sinusi spectrum, distributed to increased half life dizzines
tis, CAP, skin, gonorrhea, resp most tissue, and accumulation; n/v, coa
soft tissues, infx (cefaclor variation in kids – varies by problem
bones/joints, UTI (CAP), protein drug - Nephrot
(2nd line for kids), cefziroxine) binding, ty
STI penetration - Superin
Third some CSF varies by n
gram + and -, not generation - Renal/h
active against c dysfun
MRSA, effective Metabolism extends
against hepatic halflife
pseudomonas, less metabolism – - Anaphy
freq dosing, insignificant rxn to p
crosses BBB with don’t gi
inflammation Excretion cephalo

,3


(ceftriaxone, excreted by - Probene
omnicef (CAM) kidney incre
concent
Fourth broad n of cep
spectrum of - Loop
activity, good for diuretic
organisms that increa
developed risk for
resistance to earlier nephrot
generation y
cephalos, strep,
staph, doesn’t
penetrate CSF
(cefepime,
maxipime)
Glycopeptides Bacteriocidal Inhibits cell wall Absorption – Pregnancy Side effect
(Vancomycin – narrow gram positive synthesis and poor absorption - Category B - Irritatin
spectrum (Vancocin)) disrupts from GI tract, (oral) tissue an
(telavancin (Vibativ)- used to membrance barrier IV rapidly - Category C blood v
tx HAP or CAP when vanc function; affects absorbed; (parenteral) intima
fails) RNA synthesis vanc:52-56% - Must do - Red ma
protein bound; pregnancy syndrom
Vanc: C.diff, and telavancin: test prior to (face, ne
staph enterocolitis 90% protein telavancin torso 10
bound use mins aft
Telavancin: Lactation infusing
complicated skin Distribution – - Excreted in Adverse Effects
infections widely breast milk - Nephrot
distributed; Pediatrics - Transien
penetrates CSF - Hospitalized ototoxic
patients - Hyperse
Metabolism – only with vity
primarily given serious - Phlebiti
IV; bypasses illness injectio
first pass

Excretion –
oral vanc
(feces); Iv vanc
(renally via
glomerular
filtration);
telavancin
(primarily
urine)
Macrolides Bactericidal or Inhibits gram + Absorption – Cautions - GI upse
(Erythromycin, bacteriostatic and few gram - well absorbed - Prolongs (esp. wi
Clarithromycin, depending on in duodenum QT erythro
Azithromycin, dirithromycin, concentration; - Liver )
telithromycin) reversibly binds Distribution – impairment - Severe
to 50S ribosome distribute - Clarithromy explosiv
unit, preventing readily to body cin: watery
protein synthesis tissues, enters - CrCl diarrhea
of bacteria; CSF when <30ml/min - Acute
alkaline – meninges are requires choleste
inactivated by inflamed dosage to be hepatitis

, 4


acid; halved - Rash, fe
Metabolism – Pregnancy eosinop
metabolized in - Erythromyci - Metab.
liver, n: cat B Interacti
erythromycin, - Clarithromy esp with
heavily cin: cat C erythro
metabolized by - Azithromyci - Prolong
CYP3A4 n: cat B QT
Lactation syndrom
Excretion – - Safe maligna
excreted in Pediatrics arrthym
feces and urine, - Safe over
caution with age 6 Interactions
clarithromycin months - Colchic
increased - Warfari
renal excretion - Digoxin
increase
effect

Lincosamides Bacteriostatic in First line tx in Absorption – Cautions - GI symp
(clindamycin - Cleocin) usual doses; MRSA, primarily good oral - Asthma - Dizzine
suppresses gram +, some absorption - Severe vertigo,
protein synthesis anaerobic allergies - C.diff (
– binds to 50S pathogens Distribution – - Severe serious
subunit of the highly protein renal/liver
bacterial bound impairment
ribosome Pregnancy
Metabolism – - Category B
metabolized in - Okay for 3rd
liver trimester
Lactation
Excretion – - Present in
excreted in bile breast milk
and urine – weigh
risk/benefit
Pediatrics
- Severe infx
only
Quinolones Bactericidal for Broad spectrum; Absorption – Cautions - GI
(Levofloxacin, DNA gyrase extensive gram -; well absorbed - Renal - CNS
Ciprofloxacin, Moxifloxacin) (needed to later generations after PO admin, dysfunction: - Phototo
synthesize increased activity IV and oral can cause - Skin
bacterial DNA) against gram +; similar serum increase - Superin
only moxifloxacin concentration half-life n
has activity against with - Muscul
anaerobic bacteria; Distribution – majority of etal
PO and IV widely drug - Renal
formulations; distributed; excreted - Diabetic
resistance already high tissue, unchanged - Serious
occurring from urinary in urine effect:
inappropriate use prostate, sinus - CrCl dysrhyt
and lung <50mL/min:
penetration; adjust
variable protein dosage
binding; - Cautious in
moderately patients

Document information

Uploaded on
September 29, 2026
Number of pages
39
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
£17.90

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
DOCTORAGNES
3.0
(1)
Sold
3
Followers
0
Items
1125
Last sold
2 months ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their exams and reviewed by others who've used these revision notes.

Didn't get what you expected? Choose another document

No problem! You can straightaway pick a different document that better suits what you're after.

Pay as you like, start learning straight away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and smashed it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions